Treating Hypertension in the Workplace: Can the Numbers Be Controlled in 3 Months?  

作　　者：Asséga Sylvain Sagna Ibrahima Diarra Serigne Mor Beye Mossane Dominique Ndour Modou Mbacké Gueye Mame Thioro Aïssatou Fall Asséga Sylvain Sagna;Ibrahima Diarra;Serigne Mor Beye;Mossane Dominique Ndour;Modou Mbacké Gueye;Mame Thioro Aïssatou Fall(Boto SA, Managem Group, Kdougou, Sngal;Department of Health sciences, Gaston BERGER University, Saint-Louis, Senegal;International Committee of the Red Cross, Dakar, Senegal;West Africa Farm (WAF), Yamane, Louga, Sngal)

机构地区：[1]Boto SA, Managem Group, Kdougou, Sngal [2]Department of Health sciences, Gaston BERGER University, Saint-Louis, Senegal [3]International Committee of the Red Cross, Dakar, Senegal [4]West Africa Farm (WAF), Yamane, Louga, Sngal

出　　处：《Occupational Diseases and Environmental Medicine》2024年第4期318-324,共7页职业病与环境医学（英文）

摘　　要：Hypertension is a public health problem that affects both developed and developing countries. Senegal is making significant progress in the fight against this and other chronic, non-communicable diseases. Achieving blood pressure control within three months of treatment is an important pillar of Senegal’s strategy. The objective of this study was to evaluate the achievement of blood pressure control within three months of treatment at SCL. Our results show the need to strengthen blood pressure management skills of healthcare staff.Hypertension is a public health problem that affects both developed and developing countries. Senegal is making significant progress in the fight against this and other chronic, non-communicable diseases. Achieving blood pressure control within three months of treatment is an important pillar of Senegal’s strategy. The objective of this study was to evaluate the achievement of blood pressure control within three months of treatment at SCL. Our results show the need to strengthen blood pressure management skills of healthcare staff.

关 键 词：High Blood Pressure Non-Communicable Disease ABPM Treatment Target Senegal 

分 类 号：R54[医药卫生—心血管疾病]